Synagis (MedImmune, LLC)
Welcome to the PulseAid listing for the Synagis drug offered from MedImmune, LLC. This Antibodies, Monoclonal [Chemical/Ingredient],Fusion Protein Inhibitors [MoA],Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | MedImmune, LLC |
| NON-PROPRIETARY NAME: | palivizumab |
| SUBSTANCE NAME: | PALIVIZUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antibodies, Monoclonal [Chemical/Ingredient],Fusion Protein Inhibitors [MoA],Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1998-06-19 |
| END MARKETING DATE: | 0000-00-00 |
Synagis HUMAN PRESCRIPTION DRUG Details:
| Item Description | Synagis from MedImmune, LLC |
| LABELER NAME: | MedImmune, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/mL) |
| START MARKETING DATE: | 1998-06-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 60574-4113_11f03a0f-c7c8-4eb5-945e-61e7da9784c6 |
| PRODUCT NDC: | 60574-4113 |
| APPLICATION NUMBER: | BLA103770 |
Other PALIVIZUMAB Pharmaceutical Manufacturers / Labelers:
